Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1)
Janakiram Subramanian, MD
This content is restricted to members only.
Login Here
Forgot Password?
GET STARTED NOW
Choose the Subscription that’s Best for You
MEC Basic
- Access to Library of Conference Presentations in PDF format
- View Non-CME/CE On Demand Videos at $9.99/ea.
- Purchase On-Demand CME/CE at full price
Cost: FREE
MEC Plus
- Access to Library of Conference Presentations in PDF format
- View Unlimited Non-CME/CE On Demand Videos
- 15% Discount on any On-Demand CME/CE purchase
Cost: $299 Annually Healthcare Professionals
Cost: $499 Annually Industry Professionals
